Ditropan XL

[Oxybutynin]

DITROPAN XL ® and OROS ® are registered trademarks of ALZA Corporation.
Distributed and Marketed by Ortho-McNeil Pharmaceutical, Inc., Raritan, NJ 08869

631-10-800-1 Revised June 2003

Study 3 n DITROPAN XL ® n oxybutynin
Mean Baseline 111 18.9 115 19.5
Mean (SD) Change from Baseline* 111 -14.5 (8.7) 115 -13.8 (8.6)
95% Confidence Interval for Difference (-3.0, 1.6)**

Text Continues Below

---

(DITROPAN XL ® -oxybutynin)

DITROPAN XL ® Body System Adverse Event 5-30 mg/ day
(n= 429)
General headache 9.8 asthenia 6. 8

pain 6. 8
Digestive dry mouth 60.8 constipation 13.1

diarrhea 9.1 nausea 8.9
dyspepsia 6.8
Nervous somnolence 11.9 dizziness 6.3

Respiratory rhinitis 5.6
Special senses blurred vision 7.7 dry eyes 6.1

Urogenital urinary tract infection 5. 1

Page:  << Prev | 1 | 2